Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Araoka H"" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł :
I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases.
Autorzy :
Yamamoto H; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Uchida N; 1] Department of Hematology, Toranomon Hospital, Tokyo, Japan [2] Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Matsuno N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Kon A; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Nishida A; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Ota H; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Ikebe T; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Nakano N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Ishiwata K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Araoka H; Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
Takagi S; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Tsuji M; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Asano-Mori Y; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Yamamoto G; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Izutsu K; 1] Department of Hematology, Toranomon Hospital, Tokyo, Japan [2] Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Masuoka K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Wake A; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Yoneyama A; Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
Makino S; Department of Transfusion Medicine, Toranomon Hospital, Tokyo, Japan.
Taniguchi S; 1] Department of Hematology, Toranomon Hospital, Tokyo, Japan [2] Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2015 Apr; Vol. 50 (4), pp. 607-9. Date of Electronic Publication: 2015 Jan 26.
Typ publikacji :
Letter
MeSH Terms :
Hematologic Diseases*/mortality
Hematologic Diseases*/therapy
Transplantation Conditioning*
Busulfan/*administration & dosage
Melphalan/*administration & dosage
Vidarabine/*analogs & derivatives
Adult ; Aged ; Cord Blood Stem Cell Transplantation ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Risk Factors ; Survival Rate ; Vidarabine/administration & dosage ; Whole-Body Irradiation
Opinia redakcyjna
Tytuł :
The impact of graft cell source on bloodstream infection in the first 100 days after allogeneic hematopoietic cell transplantation.
Autorzy :
Takagi S; Department of Hematology, Toranomon Hospital, Tokyo, Japan. .
Ogura S; Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
Araoka H; Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Mitsuki T; Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
Yuasa M; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Kageyama K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Kaji D; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Taya Y; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Nishida A; Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
Kimura M; Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
Ishiwata K; Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
Yamamoto H; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Yamamoto G; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Asano-Mori Y; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Koike Y; Department of Clinical Laboratory, Toranomon Hospital, Tokyo, Japan.
Izutsu K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Wake A; Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
Makino S; Department of Transfusion Medicine, Toranomon Hospital, Tokyo, Japan.
Yoneyama A; Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.; Department of Clinical Laboratory, Toranomon Hospital, Tokyo, Japan.
Taniguchi S; Department of Hematology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jul; Vol. 56 (7), pp. 1625-1634. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article
MeSH Terms :
Bacteremia*
Communicable Diseases*
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*/adverse effects
Adult ; Humans ; Retrospective Studies ; Transplantation Conditioning/adverse effects
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies